Physician

Victor R. Mujica, MD

According to 2025 Medicare claims, Victor Mujica, MD (NPI: 1003859877) practices gastroenterology in the Waterloo-Cedar Falls, IA market, with the plurality of this provider's patient population coming from Black Hawk, IA. This provider's primary affiliated billing organization is COVENANT MEDICAL CENTER INC (NPI: 1548288160; TIN: 421264647) and primary practice location at 50702-5401. Mujica is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mujica's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 954 traditional Medicare patients, billed 2,704 HCPCS/CPT codes, and received $180,901 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,988 prescription claims across 797 beneficiaries totaling $586,240 in drug costs, led by Humira(Cf) Pen (Adalimumab). DME data shows 12 claims. Open Payments data shows 2 records totaling $85. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $505,481 and ending at $586,240. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	912	2,109	$203,668
2016	951	2,105	$185,702
2017	875	2,535	$165,793
2018	1,083	3,213	$203,520
2019	1,156	3,297	$218,140
2020	892	2,652	$176,374
2021	1,088	3,104	$209,884
2022	1,092	3,039	$199,112
2023	906	2,495	$171,873
2024	954	2,704	$180,901

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	567	1,854	$505,481
2016	580	1,787	$259,703
2017	576	1,688	$519,201
2018	684	1,957	$629,785
2019	721	2,020	$631,431
2020	671	1,875	$588,316
2021	806	1,957	$502,975
2022	732	1,980	$250,885
2023	903	2,427	$529,569
2024	797	1,988	$586,240

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	23	$588
2020	N/R	23	$527
2021	N/R	23	$1,047
2022	N/R	12	$1,514
2023	N/R	12	$1,406
2024	N/R	12	$1,146

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	221	223	$188
45380	Biopsy of large bowel using a flexible endoscope	480	482	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	123	154	$62
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	328	344	$38
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	723	772	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	34	981	$305,694
Linzess	Linaclotide	46	1,596	$29,166
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	376	677	$24,295
Mesalamine	Mesalamine	56	2,177	$12,619
Budesonide Dr	Budesonide	17	558	$3,679

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7500	Azathioprine, oral, 50 mg	N	N/R	12	$1,146

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$85	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Victor R. Mujica, MD?

Tedicare shows public-source Medicare data for Victor R. Mujica, MD (NPI 1003859877), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Victor R. Mujica, MD have ACO affiliation data?

Victor R. Mujica, MD is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Victor R. Mujica, MD?

Victor R. Mujica, MD is linked to COVENANT MEDICAL CENTER INC (billing NPI 1548288160) in the available physician profile data.

Does Victor R. Mujica, MD have Open Payments data?

Victor R. Mujica, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.